Teknovas

Activities: Dosage Forms

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Manufacturing

Alpha Teknova opens modular production facility for gene therapies

The company's modular manufacturing facility is located in Hollister, California and is set to enable bioprocessing and gene therapy companies to get into the clinic faster
Manufacturing

Expansion of proprietary AAV gene therapy product line

The AAV-Tek AEX Buffer Screening Kit was created to help streamline the identification of the ideal buffer formulation for use during AAV downstream processing
Drug Delivery

Proprietary AAV gene therapy product line to launch

The AAV-Tek AEX Buffer Screening Kit, developed by Teknova, is a proprietary, off-the-shelf selection of discrete buffers
Manufacturing

Teknova unveils new WFI quality water for bioprocessing market

The addition of WFI Quality Water to this portfolio addresses critical supply chain issues in the preparation of cell culture media, molecular biology, upstream and downstream bioprocessing, and equipment cleaning
Subscribe now